Our website uses cookies

We use cookies to help provide you with a better service. You can change your cookie settings at any time.
Otherwise, we will assume you're OK to continue. Learn more

Home
Resources for people with severe haemophilia A without factor VIII inhibitors
Resources for people with haemophilia A and inhibitors to factor VIII
Video resources

Video resources

How to prepare and administer Hemlibra using a transfer needle

An interactive video explaining what Hemlibra is and how it works

Terms and Conditions|Privacy Policy

These resources are only intended for people who have been prescribed Hemlibra by their Healthcare Professional. Please exit this site if this does not apply to you.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme www.mhra.gov.uk/yellowcard. You should also report side effects to Roche Products Ltd by emailing the Roche Drug Safety Centre at welwyn.uk_dsc@roche.com or calling +44 (0) 1707 367554. By reporting side effects you can help provide more information on the safety of this medicine.

This site has been developed by Roche Products Limited and Chugai Pharma UK Ltd

Job code: M-GB-00011834
Date of preparation: July 2023

Welcome to the Hemlibra
(emicizumab) resource centre

These resources are only intended for people living in the UK who have been prescribed Hemlibra by their Healthcare Professional.
By entering this site, you are confirming this applies to you. If this does not apply to you, please exit this page now.

Continue to site

Exit (This link will take you to the Roche corporate site)

This site has been developed by Roche Products Limited and Chugai Pharma UK Ltd

Job code: M-GB-00011834
Date of preparation: July 2023